Saratoga Investment Corp. NT 23 SAB
25.62 USD 0.00 (+0.00%)
Jan 8, 2020, 10:03 AM EST
25.62 Day range 25.74
25.67 52-week range 211,000.00
- Market cap
- 150.76M
- EPS (ttm)
- 2.94
- P/E ratio
- 8.73
- Volume
- 3.00K
- Avg volume
- 69.92K
- Open
- 25.63
- Previous close
- 25.62
- Day's range
- 25.62 – 25.74
- 52-week range
- 25.67 – 211,000.00
No chart data for this range yet.
Key statistics
- Price / sales
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- 50-day average
- 189,334.28
- 200-day average
- 188,533.58
News
Orchestra BioMed Announces Virtue SAB Presentation at TCT 2026 
SAB BIO to Host Third Quarter 2026 Financial Results Conference Call and Webcast on November 5, 2026, 08:30 AM ET 
SAB Biotherapeutics Highlights Diabetes Trial Progress, Human Antibody Platform 
Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SAB 
SAB BIO to Participate in Chardan 10th Annual Healthcare Conference 
SAB BIO Receives FDA Fast Track Designation for SAB-142 in Stage 3 Type 1 Diabetes 
SAB BIO to Present SAB-142 Data at the Inaugural Breakthrough T1D Clinical & Research Congress 
SAB BIO to Present SAB-142 Data at the 62nd Annual Meeting of the European Association for the Study of Diabetes 
SAB BIO to Participate in Upcoming Investor Conferences 
SAB Biotherapeutics Q2 Earnings Call Highlights
Your note
Sign in to keep a note on SAB — it syncs with the Stock Master app.